Fatty liver in Pakistani cohort with rheumatoid arthritis

Abstract

Objective: To determine the frequency of fatty liver (non-alcoholic) disease, Framingham 10-year cardiovascular risk score in rheumatoid arthritis patients.
 Methods: This study was conducted from September 1st to March 19, 2019, at Rheumatology OPD, Central Park Medical College Lahore. One hundred ninety two seropositive rheumatoid arthritis patients were recruited. Demographic details were noted, BP, BMI, smoking habits, and waist circumference were noted, then sent to radiology department for ultrasound scan of abdomen by an expert radiologist. On next day 10 ml blood was taken by phlebotomist for lipid profile and fasting blood sugar levels, after availability of results 10-years Framingham cardiovascular risk score was calculated.
 Results: Females were (81.3%) mean age of (45.4) years, fatty liver was present in n=39 (20.3%). In positive cases comorbid like metabolic syndrome was present (71.8%), diabetes mellitus (33.3%), hypertension (59%) FRS score (intermediate to high in (33.3%), history of hakeem/desi medication use (51.3%), while on regression analysis all study parameters except DMARD’s had significant association with fatty liver (p<0.05).
 Conclusion: Nonalcoholic fatty liver disease is very widely prevalent in rheumatoid arthritis patients. As in general population, it is multifactorial in origin and needs careful monitoring and treatment.
 doi: https://doi.org/10.12669/pjms.36.4.1984
 How to cite this:Wagan AA, Bhutoo AQ, Khan D, Raheem A. Fatty liver in Pakistani cohort with rheumatoid arthritis. Pak J Med Sci. 2020;36(4):---------. doi: https://doi.org/10.12669/pjms.36.4.1984
 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Diagnostic and therapeutic delay in Rheumatoid Arthritis patients: Impact on disease outcome

“…6 RA is associated with fatty liver and comorbidities like metabolic syndrome, diabetes mellitus and hypertension. 7 Hypertension, smoking and self-use NSAIDS/ Hakeem medication lead to impaired renal function in RA patients. 8 Initiating treatment within 12 weeks of symptoms onset (therapeutic window of opportunity) 9 doubles the chances of achieving remission and decreases necessity of using biologics in RA treatment from 32.24% to 10% 10,11 leading to better functional outcome (lower HAQ-DI values) with good radiographic outcome and lower disease progression rate.…”

“…6 RA is associated with fatty liver and comorbidities like metabolic syndrome, diabetes mellitus and hypertension. 7 Hypertension, smoking and self-use NSAIDS/Hakeem medication lead to impaired renal function in RA patients. 8 …”

Premature Ejaculatory Dysfunction in Rheumatoid Arthritis (PED-RA Study)

“…The baseline characteristics, 168 study participants, 92.3% were married, the mean age of samples was 32. 27 If RA is left untreated there is vicious circle of Pain-physical disability-psychological issues, ultimately leading to poor quality of life. Sexuality, its expression, and completion of act, is vital for healthy and diseased persons, as it's a crucial aspect of an individual's self-identity and self-esteem.…”

“…24 In RA there is wide prevalence of depression and dyslipidemia, diabetes mellitus, obesity, illicit drug use, so these might be affecting the sexual functions as well. [25][26][27] Majority of medications used for arthritis do not impairs sexual functioning, but some cases of erectile impotence and peyronie's disease have been reported with methotrexate, sulfasalazine, and hydroxychloroquine, other drugs like (cimetidine, diclofenac, misoprostol, and naproxen) may interfere with libido, loss of desire, while difficulty with orgasm are common side effects of antidepressant medications. Yet results are still far from unequivocal.…”

Effect of glucocorticoids combined with disease modifying anti-rheumatic drugs on the improvement of symptoms in patients with rheumatoid arthritis

“…1 Moreover, vasculitis can also affect the surrounding organs and tissues, including lungs, which can lead to life-threatening complications of pulmonary interstitial fibrosis. 2 In recent years, the standardized systematic treatment of rheumatoid arthritis has been continuously emphasized in clinic. In addition to symptom relief and improvement of joint function, the treatment measures focus on delaying the progress of arthritis and preventing systemic damage.…”